Point of care molecular diagnostics market Research, In-Depth Analysis, Key Players, Applications, Forecast to 2023

The global point of care molecular diagnostics market was valued at USD 632.5 Million in 2017 and is projected to reach USD 1,440.2 Million in 2023, at a CAGR of 14.7%. The scope of the study includes POC molecular diagnostics analyzers and assays that enable healthcare professionals in the detection of diseases through molecular technologies in point-of-care settings. The base year considered for the study is 2017, and the forecast for the market

To know about the assumptions considered for the study, download the pdf brochure

The key players in the global Point of care molecular diagnostics market are, Roche Diagnostics (Switzerland), Biomerieux (France), Danaher (US), Abbott Laboratories (US), Quidel (US) and Meridian Bioscience (US).

Target Audience:

  • POC Molecular Diagnostics Manufacturers
  • Physicians
  • Research Institutes
  • Diagnostics Suppliers
  • Market Research and Consulting Firms
  • Regulatory Bodies
  • Venture Capitalists

Scope of the Report:

The research report categorizes the global Point of care molecular diagnostics market into the following segments and subsegments:

  • Point of Care Molecular Diagnostics Market, by Product & Service
    • Assays & Kits
    • Instruments/Analyzers
    • Services & Software


  • Point of Care Molecular Diagnostics Market, by Application
    • Respiratory diseases
    • STDs
    • HAIs
    • Oncology
    • Hepatitis
    • Other Applications

    • Point of Care Molecular Diagnostics Market, by Technology
      • RT-PCR
      • INAAT
      • Others Technologies


  • Point of Care Molecular Diagnostics Market, by End User
    • Physician Offices
    • Hospital Emergency Departments & Intensive Care Units
    • Research Institutes
    • Other End User

Medical Devices Market Research Reports & Consulting

About MarketsandMarkets™ 


MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.


Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.


MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.



Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/point-of-care-molecular-diagnostic-market.asp

You May Also Like